Hangzhou Converd Co., Ltd.
Clinical trials sponsored by Hangzhou Converd Co., Ltd., explained in plain language.
-
Engineered virus targets tough pancreatic tumors in new trial
Disease control Recruiting nowThis study is testing a new treatment called hV01, which is a modified virus designed to infect and kill cancer cells while also boosting the immune system. It is for adults with advanced pancreatic cancer that has not responded to standard therapies. The virus is injected direct…
Phase: PHASE2 • Sponsor: Hangzhou Converd Co., Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Engineered virus teams up with immune drug to fight tough cancers
Disease control Recruiting nowThis study is testing a new two-part treatment for advanced solid tumors that have not responded to standard therapies. It combines a specially engineered virus designed to attack cancer cells with a drug that helps the immune system fight cancer. The main goals are to see if thi…
Phase: NA • Sponsor: Hangzhou Converd Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC